Jackie Mulryne
Jackie Mulryne is a seasoned regulatory life sciences practitioner who provides sophisticated regulatory, policy, and compliance advice to clients in the pharmaceutical, medical technology, cosmetics, and foods sectors. She regularly advises on complex regulatory issues that arise throughout the product life cycle, including maximizing regulatory protections and the overlap with intellectual property rights, classification of products, clinical research, authorization and approval, advertising and promotion, and market access strategy. Jackie partners with clients to develop strategies to help bring innovative products to market, and helps companies develop and implement cross-border regulatory compliance programs.
She assists life sciences and medical technology companies to navigate the medical devices and in vitro diagnostic regulatory frameworks and advises companies on launching digital health and AI technologies.
Jackie has significant experience with the EU and UK regulatory authorities responsible for overseeing these product areas, including the European Medicines Agency (EMA), the Medicines and Healthcare products Regulatory Agency (MHRA), and notified bodies. Clients turn to Jackie for assistance in contentious disputes due to her extensive background in public and administrative law litigation, assisting clients with sensitive internal investigations and regulatory inspections, and defending enforcement actions by the competent authorities. She also coordinates such matters across Europe. Jackie advises on a wide range of actions arising from the decisions of regulatory bodies and represents clients challenging public procurement tenders.
Committed to pro bono work, Jackie has acted for several organizations and individuals before the UK and international courts.
